Multivariable adjusted hazard ratios for time to death
| Medication/category | Median time until death (Q1, Q3), min* | HR (95% CI) |
|---|---|---|
| Lidocaine (Ref = none) | 8 (6, 10) | |
| Low-dose | 6 (7, 12) | 0.8 (0.6–1.0) |
| Standard-dose | 9 (6, 12) | 0.6 (0.6–0.7) |
| High-dose | 8 (6, 10) | 0.8 (0.7–0.9) |
| Propofol (Ref = low-dose) | 8 (5, 11) | |
| None | 7 (6, 15) | 1.4 (0.5–1.0) |
| Standard-dose | 9 (6, 12) | 0.9 (0.8–1.0) |
| High-dose | 12 (8, 16) | 0.4 (0.3–0.5) |
| Paralytic (Ref = standard-dose rocuronium) | 9 (6, 12) | |
| Rocuronium | ||
| Low-dose | 9 (6, 11) | 0.9 (0.8–1.0) |
| High-dose | 14 (8, 22) | 0.4 (0.3–0.7) |
| Cisatracurium | ||
| Standard-dose | 9 (12, 13) | 1.0 (0.9–1.0) |
| Low-dose | 14† | 0.8 (0.1–5.6) |
| High-dose | 17 (14, 43) | 0.4 (0.1–1.3) |
| Bupivacaine (Ref = none) | 9 (6, 12) | |
| Low-dose | 8 (5, 12) | 1.0 (0.8–1.3) |
| Standard-dose | 8 (5, 12) | 1.2 (1.0–1.3) |
| High-dose | 8 (6, 20) | 0.7 (0.4–1.2) |
| Potassium chloride (Ref = none) | 9 (6, 12) | |
| Low-dose | 10 (8, 13) | 1.3 (0.5–3.5) |
| Standard-dose | 7 (5, 9) | 1.2 (0.9–1.4) |
| High-dose | 14 (11, 15) | 0.7 (0.3–1.6) |